Vera Therapeutics (VERA) Operating Income (2020 - 2026)
Vera Therapeutics (VERA) posted Operating Income of -$125.1 million for Q1 2026, down 32.83% on a QoQ basis from -$94.2 million in Q4 2025, and down 118.79% year-over-year from $666.1 million in Q1 2025.
Vera Therapeutics (VERA) Operating Income (2020 - 2026) Analysis & Trends
Vera Therapeutics' Operating Income history runs 7 years deep, the most recent figure standing at -$125.1 million for Q1 2026.
- Quarterly Operating Income fell 118.79% year-over-year to -$125.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$383.4 million (down 98.4% YoY) and the FY2025 annual result came in at -$315.5 million, down 88.71% from the prior year.
- Operating Income was -$125.1 million for Q1 2026 at Vera Therapeutics, down from -$94.2 million in the prior quarter.
- Across five years, Operating Income topped out at -$15.1 million in Q2 2022 and bottomed at -$125.1 million in Q1 2026.
- A 5-year average of -$47.1 million and a median of -$33.6 million in 2022 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income slumped 260.92% — and 2023, when it advanced 19.51%.
- Vera Therapeutics' Operating Income stood at -$33.6 million in 2022, then gained by 19.51% to -$27.0 million in 2023, then tumbled by 80.98% to -$48.9 million in 2024, then slumped by 92.6% to -$94.2 million in 2025, then sank by 32.83% to -$125.1 million in 2026.
- Business Quant data shows VERA's Operating Income at -$125.1 million in Q1 2026, -$94.2 million in Q4 2025, and -$83.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - | -125.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -125.13 Mn |
| Dec 31, 2025 | -94.21 Mn |
| Sep 30, 2025 | -83.93 Mn |
| Jun 30, 2025 | -80.14 Mn |
| Mar 31, 2025 | -57.19 Mn |
| Dec 31, 2024 | -48.91 Mn |
| Sep 30, 2024 | -49.80 Mn |
| Jun 30, 2024 | -37.34 Mn |
| Mar 31, 2024 | -31.11 Mn |
| Dec 31, 2023 | -27.03 Mn |
| Sep 30, 2023 | -21.76 Mn |
| Jun 30, 2023 | -21.97 Mn |
| Mar 31, 2023 | -31.26 Mn |
| Dec 31, 2022 | -33.58 Mn |
| Sep 30, 2022 | -25.24 Mn |
| Jun 30, 2022 | -15.06 Mn |
| Mar 31, 2022 | -17.02 Mn |
| Dec 31, 2021 | -16.59 Mn |
| Sep 30, 2021 | -7.25 Mn |
| Jun 30, 2021 | -5.85 Mn |